Irish startup FIRE1 has raised $120 million to enhance its Norm system, a heart failure monitor implant designed to let patients manage their condition at home and avoid costly hospital stays. With total funding now reaching $210 million, the company aims to conduct pivotal clinical trials and seek FDA approval by 2029, promising improved patient management through direct fluid volume measurements. Source and details of the news